CYSTINE TRYPTIC AGAR W/DEXTROSE— 510(k) K844542

Substantially Equivalent

bioMerieux, Inc.

FDA 510(k) clearance K844542 for CYSTINE TRYPTIC AGAR W/DEXTROSE, Substantially Equivalent on 1985-01-16. Applicant: bioMerieux, Inc.. Device class: 1.

Clearance details

Applicant
bioMerieux, Inc.
Product code
Code JSF
Device class
Class 1
Regulation
21 CFR 866.2320
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Addison, IL, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code JSF

view all

More clearances from bioMerieux, Inc.

view all

Data sourced from openFDA. This site is unofficial and independent of the FDA.